Skip to main content

Advertisement

SpringerLink
Log in

Impact of Opioid Pharmacotherapy on Arterial Stiffness and Vascular Ageing: Cross-Sectional and Longitudinal Studies

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Whilst there is a small literature on the cardiovascular toxicity of opiates, there is no detailed antemortem data on non-cardiovascular patient populations. A cross-sectional and longitudinal naturalistic observational study was performed comparing methadone (N = 71)-, buprenorphine (N = 593)-, naltrexone (N = 23)-treated patients with controls (N = 576) on indices of arterial stiffness and vascular age by Pulse Wave Analysis in primary care, 2006–2011. Controls were younger 29.96 ± 0.45 (mean ± SEM) vs. 34.00 ± 0.34–39.22 ± 1.11 years (all P < 0.005) and had fewer smokers (15.9 % vs. 86.9 %–92.96 %, all P < 0.0001). The sex ratio was similar (69.6 vs. 67.7 % male, P = 0.46). These baseline differences were controlled for by multiple regression. Linear regression of vascular age, central augmentation pressure, central augmentation index and other measures against chronologic age showed significant protective effects by treatment group against the treatment standard of methadone, in both sexes in additive and interactive models (all P < 0.02). Interactive terms in treatment type remained significant including all conventional risk factors accounting for differing opiate exposures. The principal findings from multiple regression were confirmed in the time series analysis up to 5 years by repeated measures nonlinear regression. These studies show that the deleterious impact of chronic opiate pharmacotherapy on vascular age and arterial stiffness varies significantly by treatment type.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Centers for Disease Control, Prevention (CDC). (2011). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. Morbidity and Mortality Weekly Report, 60, 1487–1492.

    Google Scholar 

  2. Jamison, R. N., Serraillier, J., & Michna, E. (2011). Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Research and Treatment, 2011, 941808.

    Article  PubMed  Google Scholar 

  3. Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence, 105(1–2), 9–15.

    Article  PubMed  Google Scholar 

  4. Kimber, J., Copeland, L., Hickman, M., Macleod, J., McKenzie, J., De Angelis, D., et al. (2010). Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ (Clinical research ed), 341, c3172.

    Article  Google Scholar 

  5. Brunton, L. L., Lazo, J. S., & Parker, K. L. (Eds.). (2006). Goodman and Gilman’s the pharmacologic basis of therapeutics (11th ed., Vol. 1). New York: McGraw Hill.

    Google Scholar 

  6. McLaughlin, P. J., Zagon, I. S., & White, W. J. (1978). Perinatal methadone exposure in rats. Effects on body and organ development. Biology of the Neonate, 34(1–2), 48–54.

    PubMed  CAS  Google Scholar 

  7. Cheng, F., McLaughlin, P. J., Verderame, M. F., & Zagon, I. S. (2009). The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation. Molecular Biology of the Cell, 20(1), 319–327.

    Article  PubMed  CAS  Google Scholar 

  8. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., et al. (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science, 316(5830), 1491–1493.

    Article  PubMed  CAS  Google Scholar 

  9. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., et al. (2007). A common allele on chromosome 9 associated with coronary heart disease. Science, 316(5830), 1488–1491.

    Article  PubMed  CAS  Google Scholar 

  10. Feero, W. G., Guttmacher, A. E., & McCarthy, M. I. (2010). Genomics, Type 2 diabetes, and obesity. New England Journal of Medicine, 363(24), 2339–2350.

    Article  Google Scholar 

  11. O’Donnell, C. J., & Nabel, E. G. (2011). Genomics of cardiovascular disease. New England Journal of Medicine, 365(22), 2098–2109.

    Article  PubMed  Google Scholar 

  12. Pasmant, E., Sabbagh, A., Vidaud, M., & Bieche, I. (2010). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. The FASEB Journal, 25(2), 444–448.

    Article  Google Scholar 

  13. Holdt, L. M., Beutner, F., Scholz, M., Gielen, S., Gabel, G., Bergert, H., et al. (2010). ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(3), 620–627.

    Article  PubMed  CAS  Google Scholar 

  14. Khademi, H., Malekzadeh, R., Pourshams, A., Jafari, E., Salahi, R., Semnani, S., et al. (2012). Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50, 000 adults in Iran. BMJ (Clinical research ed), 344, e2502.

    Article  Google Scholar 

  15. Darke, S., Kaye, S., & Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction, 101(9), 1299–1305.

    Article  PubMed  Google Scholar 

  16. Sadeghian, S., Darvish, S., Davoodi, G., Salarifar, M., Mahmoodian, M., Fallah, N., et al. (2007). The association of opium with coronary artery disease. European Journal of Cardiovascular Prevention & Rehabilitation, 14(5), 715–717.

    Article  Google Scholar 

  17. Sadeghian, S., Dowlatshahi, S., Karimi, A., & Tazik, M. (2011). Epidemiology of opium use in 4398 patients admitted for coronary artery bypass graft in Tehran Heart Center. The Journal of Cardiovascular Surgery (Torino), 52(1), 140–141.

    CAS  Google Scholar 

  18. Claude Bernard, M. (1877). Lecons Sur Le Diabete et la Glycogenese Animale (Vol. 1). Paris: Cours de Medecine.

    Google Scholar 

  19. Rosen, D., Smith, M. L., & Reynolds, C. F., 3rd. (2008). The prevalence of mental and physical health disorders among older methadone patients. American Journal of Geriatric Psychiatry, 16(6), 488–497.

    Article  PubMed  Google Scholar 

  20. Cooper, O. B., Brown, T. T., & Dobs, A. S. (2003). Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clinical Infectious Diseases, 37(Suppl 2), S132–S136.

    Article  PubMed  CAS  Google Scholar 

  21. Kolarzyk, E., Pach, D., Wojtowicz, B., Szpanowska-Wohn, A., & Szurkowska, M. (2005). Nutritional status of the opiate dependent persons after 4 years of methadone maintenance treatment. Przeglad Lekarski, 62(6), 373–377.

    PubMed  Google Scholar 

  22. Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 106(1), 1–6.

    Article  PubMed  CAS  Google Scholar 

  23. Reece, A. S. (2009). Dental health in addiction. Australian Dental Journal, 54(2), 185–186.

    Article  PubMed  Google Scholar 

  24. Friedewald, V. E., Kornman, K. S., Beck, J. D., Genco, R., Goldfine, A., Libby, P., et al. (2009). The American Journal of Cardiology and Journal of Periodontology editors’ consensus: periodontitis and atherosclerotic cardiovascular disease. Journal of Periodontology, 80(7), 1021–1032.

    Article  PubMed  Google Scholar 

  25. Zagon, I. S., Verderame, M. F., & McLaughlin, P. J. (2002). The biology of the opioid growth factor receptor (OGFr). Brain Research Reviews, 38(3), 351–376.

    Article  PubMed  CAS  Google Scholar 

  26. Nichols, W. W., Denardo, S. J., Wilkinson, I. B., McEniery, C. M., Cockcroft, J., & O’Rourke, M. F. (2008). Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. The Journal of Clinical Hypertension (Greenwich), 10(4), 295–303.

    Article  Google Scholar 

  27. Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., et al. (2001). Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension, 37(5), 1236–1241.

    Article  PubMed  CAS  Google Scholar 

  28. AtCor Medical Corporation. (2006). SphygmoCor pulse wave analysis system model SCOR-Px. PP1–63 (1st ed., Vol. 1). Sydney: Atcor Medical.

    Google Scholar 

  29. Reece, A. S. (2007). Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse Treatment, Prevention, and Policy, 2, 35–49.

    Article  PubMed  CAS  Google Scholar 

  30. Hulse, G., White, J., & Cape, G. (Eds.). (2002). Management of drug and alcohol problems (Vol. 1). Sydney: Oxford University Press.

    Google Scholar 

  31. Kienbaum, P., Thurauf, N., Michel, M. C., Scherbaum, N., Gastpar, M., & Peters, J. (1998). Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology, 88(5), 1154–1161.

    Article  PubMed  CAS  Google Scholar 

  32. Chien, K. R., & Karsenty, G. (2005). Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell, 120(4), 533–544.

    Article  PubMed  CAS  Google Scholar 

  33. Visel, A., Zhu, Y., May, D., Afzal, V., Gong, E., Attanasio, C., et al. (2010). Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature, 464(7287), 409–412.

    Article  PubMed  CAS  Google Scholar 

  34. Harismendy, O., Notani, D., Song, X., Rahim, N. G., Tanasa, B., Heintzman, N., et al. (2011). 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature, 470(7333), 264–268.

    Article  PubMed  CAS  Google Scholar 

  35. Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., et al. (2010). Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity, 24(1), 83–95.

    Article  PubMed  CAS  Google Scholar 

  36. Yin, D., Woodruff, M., Zhang, Y., Whaley, S., Miao, J., Ferslew, K., et al. (2006). Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3 K/Akt/NF-kappaB pathways. Journal of Neuroimmunology, 174(1–2), 101–107.

    Article  PubMed  CAS  Google Scholar 

  37. Grzanna R., & Brown R. M. (1993). NIDA research monograph 125: Activation of intermediate early genes by drugs of abuse. In: National Institutes of Drug Abuse (Ed.) (Vol. 125, pp. 1–220). Bethesda, Maryland: NIH.

  38. Varela, E., & Blasco, M. A. (2010). 2009 Nobel Prize in physiology or medicine: telomeres and telomerase. Oncogene, 29(11), 1561–1565.

    Article  PubMed  CAS  Google Scholar 

  39. Martinez, P., & Blasco, M. A. (2011). Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nature Reviews Cancer, 11(3), 161–176.

    Article  PubMed  CAS  Google Scholar 

  40. Martinez, P., Thanasoula, M., Carlos, A. R., Gomez-Lopez, G., Tejera, A. M., Schoeftner, S., et al. (2010). Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nature Cell Biology, 12(8), 768–780.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. School of Psychiatry and Clinical Neurosciences, University of Western Australia, 39 Gladstone Rd., Highgate Hill, Brisbane, QLD, Australia

    Albert Stuart Reece & Gary Kenneth Hulse

Authors
  1. Albert Stuart Reece
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary Kenneth Hulse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Stuart Reece.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPT 451 kb)

Supplementary material 2 (DOC 119 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reece, A.S., Hulse, G.K. Impact of Opioid Pharmacotherapy on Arterial Stiffness and Vascular Ageing: Cross-Sectional and Longitudinal Studies. Cardiovasc Toxicol 13, 254–266 (2013). https://doi.org/10.1007/s12012-013-9204-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-013-9204-4

Keywords

Search

Navigation